NCT01964547 A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients Status COMPLETED Phase PHASE4
NCT01943682 Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT01918735 A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01898520 A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years Status COMPLETED Phase PHASE3
NCT01887301 Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients Status COMPLETED Phase PHASE1
NCT01886105 Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma Status TERMINATED Phase PHASE2
NCT01843634 Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia Status COMPLETED Phase EARLY_PHASE1
NCT01812616 A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01812603 A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01769170 A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Status COMPLETED Phase PHASE3
NCT01696084 Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT01681121 A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy Status COMPLETED Phase PHASE2
NCT01643408 A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy Status COMPLETED Phase PHASE2
NCT01610713 An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01610700 An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients Status COMPLETED Phase PHASE3
NCT01610687 A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01606202 A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury Status COMPLETED Phase PHASE3
NCT01606189 A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain Status COMPLETED Phase PHASE3
NCT01606176 A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin Status COMPLETED Phase PHASE3